How to Develop RNA Vaccines from Concept to Clinic

17 Jan, 2022 | Newsletters
How to Develop RNA Vaccines from Concept to Clinic
Recorded sessions now available for viewing: Vaccines from Concept to Clinic
Explore the experiences and insights from the front lines of RNA vaccine research. Particularly, stories highlighting the challenges and solutions faced when developing RNA vaccines from the earliest stages through to the clinic.   


The Vaccine Evolution
View the Recording

Accelerate the Preclinical Development of RNA Vaccines
View the Recording

Ehrlichia mRNA Vaccines: Overcoming the Vaccine Development Roadblock
View the recording

RNA Manufacturing: Considerations to Accelerate the Path to Clinic
View the Recording

Scale Up and Manufacturing of Self-Amplifying RNA-LNPs for a COVID-19 vaccine
View the recording

Flexible Approaches to Addressing mRNA Vaccine Demand
View the Recording
Bookings are available now. Should you wish to use this instrument or need further information regarding training or help to create lipid, polymer or hybrid nanoparticle formulations carrying small molecules, peptides nucleic acids (and more), please contact Peter Davis,, or call Peter directly on his mobile 0417 778 971.  

Take a closer look:
Book your NanoAssemblr Ignite demo

Rapid, reproducible and scalable manufacture of nanoparticle formulations 
Finely tune particle size with precise control over fluid flow rates using laminar flow conditions
Create highly reproducible mRNA LNPs with high mRNA encapsulation efficacy and potency within seconds.  Simplify and accelerate nanomedicine formulation using one single mixing element — from formulation to full GMP   Precision NanoSystems’ Genetic Vaccine Toolkit provides essential technologies to facilitate development of mRNA vaccines – Click here.
Contact us for a demo
Request a quote now
Email us for more info